Exploring interieukin-JQ Levels in Diabetes Patients with and without Oral Diseases: A Systematic Review

Aim: Interleukin-10 (IL-10) is a cytokine that plays an important role in the progression of diabetes mellitus (DM). Oral diseases were more common in diabetics than in non-diabetics. The aim of this review is to identify IL-10 levels in diabetic patients with and without oral diseases. Methods: A s...

Full description

Saved in:
Bibliographic Details
Published inJournal of inflammation research Vol. 17; p. 541
Main Authors Novianti, Yessy, Nur'aen, Nanan
Format Journal Article
LanguageEnglish
Published Dove Medical Press Limited 29.02.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aim: Interleukin-10 (IL-10) is a cytokine that plays an important role in the progression of diabetes mellitus (DM). Oral diseases were more common in diabetics than in non-diabetics. The aim of this review is to identify IL-10 levels in diabetic patients with and without oral diseases. Methods: A systematic review was conducted based on the PRISMA guidelines. Three databases (PubMed, Cochrane Library, and Science Direct) were used to search for articles up to November 2023 for studies on the measurement of IL-10 in diabetics with and without oral disease. The criteria were limited to human studies and full-text in English only. The outcome was the value of IL-10. The study was quality-graded using the Risk of Bias Assessment Tool for Non-randomized Studies (RoBANS). Results: There were eleven articles that met the eligibility criteria for analysis. Four articles discovered higher IL-10 levels, while seven articles discovered lower IL-10 levels in diabetes patients with oral diseases compared with each control group. Conclusion: Most studies showed lower IL-10 levels in diabetic patients with oral diseases compared with the control group. Keywords: anti-inflammatory, candidiasis, cytokine, insulin resistance, periodontitis
ISSN:1178-7031
1178-7031
DOI:10.2147/JIR.S449546